Joe Green
COO at Orgenesis Inc (ORGS)- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Dan Ardito
Joe was an extremely valuable and trusted employee in his role in our Derivatives Accounting group. I had great comfort knowing that whatever task Joe was responsible for would be completed in a prompt and professional manner where quality and accuracy are paramount. Joe is a true team player and it was a pleasure working with him.
Dan Ardito
Joe was an extremely valuable and trusted employee in his role in our Derivatives Accounting group. I had great comfort knowing that whatever task Joe was responsible for would be completed in a prompt and professional manner where quality and accuracy are paramount. Joe is a true team player and it was a pleasure working with him.
Dan Ardito
Joe was an extremely valuable and trusted employee in his role in our Derivatives Accounting group. I had great comfort knowing that whatever task Joe was responsible for would be completed in a prompt and professional manner where quality and accuracy are paramount. Joe is a true team player and it was a pleasure working with him.
Dan Ardito
Joe was an extremely valuable and trusted employee in his role in our Derivatives Accounting group. I had great comfort knowing that whatever task Joe was responsible for would be completed in a prompt and professional manner where quality and accuracy are paramount. Joe is a true team player and it was a pleasure working with him.
Experience
-
Orgenesis Inc.
-
United States
-
Biotechnology
-
1 - 100 Employee
-
COO
-
Jan 2019 - Present
Orgenesis is a vertically-integrated biopharmaceutical company with unique expertise and experience in cell therapy development and manufacturing. Orgenesis is also developing its own propriety cell therapies. Through its subsidiary Orgenesis Ltd., Orgenesis is a pioneer in the process of Transdifferentiation (or cell reprograming), whereby an adult cell is converted into another type of cell, with its distinct phenotype and function. Orgenesis has utilized its proprietary technology/processes to successfully reprogram human liver cells into glucose-responsive, fully functional, insulin producing cells. Converting the diabetic patient's own tissue into insulin-producing cells has the potential to provide a practical cure for insulin dependent diabetes and overcome the significant issues of donor shortage, cost and exposure to chronic immunosuppressive therapy associated with islet cell transplantation. Show less
-
-
-
GreenShpits
-
Israel
-
Software Development
-
Co-Founder
-
Nov 2009 - Present
GreenShpits is a partnership between two friends who believe everyone should have his own iPhone App. We specialize in consulting, developing and marketing iPhone Apps. to date, we've developed over 80 different Apps, free or paid. You can check out our work at our website (www.greenshpits.com). If you have a cool idea for an App email ma and I'll be happy to listen and give our advice, and if you desire - build your App for you. GreenShpits is a partnership between two friends who believe everyone should have his own iPhone App. We specialize in consulting, developing and marketing iPhone Apps. to date, we've developed over 80 different Apps, free or paid. You can check out our work at our website (www.greenshpits.com). If you have a cool idea for an App email ma and I'll be happy to listen and give our advice, and if you desire - build your App for you.
-
-
-
Signals Analytics (Acquired by Kenshoo, now Skai)
-
IT Services and IT Consulting
-
1 - 100 Employee
-
COO, Legal & Compliance Officer
-
2008 - Jan 2019
Signals Analytics (www.signals-analytics.com) is a Decision Science as a Service company that enables global organizations to continuously experience the “aha moment” through Signals Playbook™, a cloud-based analytical intelligence platform that transforms the world’s unconnected data into actionable insights to enhance customer experience, optimize product portfolio health and propel innovation. Signals Playbook™ is built upon the revolutionary Signals Hive™, a machine learning foundation with military heritage that utilizes the principles of swarm computing, artificial intelligence and linguistic processing to unlock the hidden business value from diverse, unstructured data sources. Leading companies, including Procter & Gamble, Nestle, Johnson & Johnson, Bayer, General Motors and 3M, have partnered with Signals Analytics to anticipate and react to change, optimize commercial decision making and drive superior business outcomes with less risk. Backed by Sequoia Capital, Qumra Capital and TPY Capital, Signals Analytics was dubbed “The App Store for Innovation" by Forbes, awarded Cool Vendor of 2016 by Gartner and honored the last two years as a Deloitte Fast 50 Technology Company. Show less
-
-
-
-
Associate
-
May 2006 - Jul 2008
-
-
-
-
Derivatives Analyst
-
2004 - 2006
-
-
-
Meitar | Law Offices
-
Israel
-
Law Practice
-
500 - 600 Employee
-
Law intern
-
2000 - 2001
-
-
Education
-
Questrom School of Business, Boston University
MBA, Finance -
Reichman University
LLB, Law